Related Experiment Video
Updated: May 7, 2026
04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
Serum fetuin-A levels following recombinant human thyroid-stimulating hormone stimulation
Annemarie Gagnon1, Hussein Abujrad, Clara Irobi
1. asorisky@ohri.ca.
Summary
Thyroid-stimulating hormone (TSH) does not affect fetuin-A levels, a protein linked to metabolic disorders. This study found no change in fetuin-A during recombinant TSH (rhTSH) stimulation for thyroid cancer surveillance.
Area of Science:
- Endocrinology
- Metabolic Research
- Oncology
Background:
- Fetuin-A is a hepatokine associated with lipid metabolism, obesity, insulin resistance, type 2 diabetes, and cardiovascular disease.
- Elevated thyroid-stimulating hormone (TSH) levels are linked to metabolic and cardiovascular disturbances.
Purpose of the Study:
- To investigate whether TSH can regulate serum fetuin-A levels.
- To determine the effect of recombinant human TSH (rhTSH) stimulation on fetuin-A in patients undergoing thyroid cancer surveillance.
Main Methods:
- Serum fetuin-A levels were measured in 26 post-thyroidectomy patients receiving rhTSH stimulation.
- Blood samples were collected before rhTSH administration and on days 3 and 5 post-administration.
- Patients continued L-thyroxine therapy throughout the study.
Main Results:
- The mean baseline serum fetuin-A level was 527±186 mg/L.
- Serum fetuin-A levels did not significantly change following rhTSH administration.
- This lack of response was consistent across different genders, ages, baseline free thyroxine levels, and BMIs.
Conclusions:
- TSH does not appear to influence serum fetuin-A levels in the context of rhTSH administration for thyroid cancer surveillance.
- Further research is needed to fully elucidate the relationship between TSH and fetuin-A in metabolic and inflammatory conditions.
Related Concept Videos
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:18Functions of Thyroid Hormones
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:24Serum Studies: Renal Function Tests
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.